April 20, 2010
Section : Patient care

The Bipolar Disorders Program is a superspecialized (third-line) consultation and treatment service for adults aged 18 to 65 who suffer from refractory bipolar disorders.

April 20, 2010
Section : Patient care

The Mood, Anxiety and Impulsivity Disorders Program at the Douglas Institute provides care to people aged 18 to 65 years with a mood disorder such as Bipolar disorders or Depressive and suicide disorders.

April 20, 2010
Section : Patient care

Outpatient clinics for children 18 and undre include the Pervasive Developmental Disorders (PDD) Diagnostic Clinic, the Depressive Disorders Clinic and the Child Psychiatry Outpatient Clinic.

October 06, 2025
Section : Patient care

The Child Psychiatry Program at the Douglas Institute offers a range of bilingual services to youth aged 0 to 17 years and their families.

October 06, 2025
Section : Mental Health Info

Cognitive remediation is a computer-assisted therapy that promotes the stimulation of cognitive skills necessary for everyday life. Many studies have shown this therapy to have a measurable impact on cognitive deficits related to dementia, making it an invaluable intervention tool in the treatment of Alzheimer's disease.

September 12, 2011
Section : The Douglas

Profile of Willine Rozefort, Acting Director of Professional and Hospital Services, Douglas Institute

September 29, 2009
Section : The Douglas

Gérard Lebel is a liaison for the Evaluation-Liaison Module, a service that responds to requests for psychiatric consultations from individuals referred by a physician.

September 29, 2009
Section : Research

Howard Steiger contributed to the advancement of knowledge regarding causal mechanisms and clinical management of eating disorders.

September 29, 2009
Section : Research

Eric Latimer, PhD, is a health economist and looks for ways to improve the services to people with severe forms of mental illness.

September 29, 2009
Section : Research

Serge Gauthier has contributed to the development of new diagnostic and therapeutic approaches to Alzheimer's Disease and other dementing disorders.